New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
0
6

Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study

Objectives To compare stratified event rates from randomized controlled trials with predicted event rates from models developed in observational data, and assess their ability to accurately capture observed rates of thromboembolism and major bleeding for patients treated with dabigatran or warfarin as part of routine care.  
feeds.bmj.com
almost 4 years ago
Preview
0
6

Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study

Objectives To compare stratified event rates from randomized controlled trials with predicted event rates from models developed in observational data, and assess their ability to accurately capture observed rates of thromboembolism and major bleeding for patients treated with dabigatran or warfarin as part of routine care.  
feeds.bmj.com
almost 4 years ago
Preview
0
6

Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study

Objectives To compare stratified event rates from randomized controlled trials with predicted event rates from models developed in observational data, and assess their ability to accurately capture observed rates of thromboembolism and major bleeding for patients treated with dabigatran or warfarin as part of routine care.  
feeds.bmj.com
almost 4 years ago
Preview
0
0

NOACs Best Warfarin in Mortality Meta-analysis

Dr Goldhaber comments on a study that shows a lower risk for early mortality in patients who took NOACs compared with those who took warfarin.  
medscape.com
almost 4 years ago
Preview
0
0

Valvular AF With HF Common, Often Untreated in Young Africans

Other issues in sub-Saharan Africa: access can be limited and follow-ups less likely, making it tough to monitor warfarin; yet the NOACs tend to be prohibitively expensive, caution researchers.  
medscape.com
almost 4 years ago
Preview
0
10

Predicting Adverse Events With Dabigatran or Warfarin in AF

This study examined various models that aim to quantify expected rates of thromboembolism and major bleeding for a given patient if that patient were to initiate treatment with dabigatran or warfarin  
medscape.com
almost 4 years ago